Emelia J. Benjamin, MD, ScM, Boston University Chobanian and Avedisian School of Medicine, is the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award. Here she describes what atrial fibrillation is, how the condition announces itself, and why this area of cardiovascular medicine is receiving so much attention.
Emelia J. Benjamin, MD, ScM, is associate provost for faculty development at Boston University Medical Campus; cardiologist at Boston Medical Center, a large urban safety net hospital; professor of medicine, Department of Medicine, at Boston University Chobanian and Avedisian School of Medicine; and professor of epidemiology, Boston University School of Public Health.
At this year’s American Society for Preventive Cardiology’s Congress on CVD Prevention, she delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award—having received the honor for her extraordinary contributions to the field of preventive cardiology.
Here she describes what atrial fibrillation is, how the condition announces itself, and why this area of cardiovascular medicine is receiving so much attention.
Transcript
Can you explain what atrial fibrillation is and discuss how this cardiac condition presents itself?
Atrial fibrillation is an irregularly irregular heart rhythm. People may notice it if they have some kind of fitness device or some kind of heart rate tracking device; they may notice that their heart seems to be skipping or isn't going boom, boom, boom, but rather, ba boom, ba ba ba ba boom, boom, boom, boom like that. Sometimes people even feel it in their chest. On the other hand, oftentimes people are asymptomatic and the concern is that oftentimes their first presentation in the condition is a complication from atrial fibrillation.
Why is the need to focus on atrial fibrillation becoming so much more important at present?
Thank you so much for the question. I personally think that probably part of the problem is ageism, is that for many, many years, the conditions that were most studied happened in younger individuals. Now people are living longer with both cardiovascular disease and many other conditions, and so are going on to develop conditions such as atrial fibrillation. It turns out that the lifetime risk of atrial fibrillation for people of European ancestry is about 1 in 3, for people of African ancestry is about 1 in 5—so it's a very common condition that occurs more and more as people age.
In terms of why is it important now, it's increasing in incidence, meaning the number of new cases; prevalence, the number of existing cases; the lifetime risk; and the complications are significant, including stroke, coronary heart disease, myocardial infarction, heart failure. Turns out there's many other conditions that it’s associated with.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More